Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2009

Dec 11, 2009

29750_dirs_2009-12-11_1896004a-8e20-474a-969f-33dc254735a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2009-12-10

Reporting Person: Foster-Cheek Kaye I (VP, Human Resources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-10 Common M 13250 $53.00 Acquired 17679 Direct
2009-12-10 Common Stock M 11500 $53.93 Acquired 29179 Direct
2009-12-10 Common Stock M 71992 $58.34 Acquired 101171 Direct
2009-12-10 Common Stock S 96742 $64.76 Disposed 4583 Direct
2009-11-30 Common J 8 Acquired 1147 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-12-10 Employee Stock Options (Right to Buy) $53.00 M 13250 Disposed 2013-05-22 Common Stock (13250) Direct
2009-12-10 Employee Stock Option (Right to Buy) $53.93 M 11500 Disposed 2014-02-07 Common Stock (11500) Direct
2009-12-10 Employee Stock Option (Right to Buy) $58.34 M 71992 Disposed 2016-02-12 Common Stock (71992) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common 33 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Phantom Stock Units $ Common Stock (0) 5953 Direct

Footnotes

F1: Includes 819 shares held under Issuer's Dividend Reinvestment Program.

F2: This transaction was executed in multiple trades at prices ranging from $64.68 to $64.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (11/30/2009).

F4: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (11/30/2009).

F5: The Phantom Stock converts into common stock on a one-for-one basis.

F6: Phantom Stock Units held under the Issuer's Executive Income Deferral Plan are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.

F7: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.